Guest editors: Giuseppe Leone and Lodovico Balducci
Perspectives
TREATMENT OF CANCER IN THE OLDER AGED PERSON
Abstract 831 | PDF Downloads 592 HTML Downloads 3285 | DOI https://doi.org/10.4084/mjhid.2010.029Page e2010029
Review Articles
ROLE OF COMORBIDITIES IN OPTIMIZING DECISION-MAKING FOR ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
Abstract 695 | PDF Downloads 366 HTML Downloads 2154 | DOI https://doi.org/10.4084/mjhid.2010.015Page e2010015
CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
Abstract 1104 | PDF Downloads 523 HTML Downloads 2178 | DOI https://doi.org/10.4084/mjhid.2010.017Page e2010017
OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION FOLLOWING REDUCED-INTENSITY CONDITIONINIG REGIMEN IN PATIENTS WITH IDIOPATHIC MYELOFIBROSIS: THE G.I.T.M.O. EXPERIENCE AND REVIEW OF THE LITERATURE
Abstract 972 | PDF Downloads 565 HTML Downloads 702 | DOI https://doi.org/10.4084/mjhid.2010.010Page e2010010
APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA
Abstract 1306 | PDF Downloads 414 HTML Downloads 2318 | DOI https://doi.org/10.4084/mjhid.2010.011Page e2010011
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
Abstract 974 | PDF Downloads 539 HTML Downloads 881 | DOI https://doi.org/10.4084/mjhid.2010.026Page e2010026
THE TREATMENT OF MULTIPLE MYELOMA PATIENTS NOT ELIGIBLE FOR ASCT
Abstract 768 | PDF Downloads 412 HTML Downloads 522 | DOI https://doi.org/10.4084/mjhid.2010.009Page e2010009
"ROLE OF ALLOGENEIC TRANSPLANTATION IN MULTIPLE MYELOMA IN THE ERA OF NEW DRUGS"
Abstract 870 | PDF Downloads 436 HTML Downloads 1420 | DOI https://doi.org/10.4084/mjhid.2010.013Page e2010013
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
Abstract 934 | PDF Downloads 493 HTML Downloads 630 | DOI https://doi.org/10.4084/mjhid.2010.021Page e2010021
ROLE AND TIMING OF HEMATOPOIETIC CELL TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME
Abstract 888 | PDF Downloads 363 HTML Downloads 1097 | DOI https://doi.org/10.4084/mjhid.2010.019Page e2010019
How I Treat
ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN THE TREATMENT OF CHRONIC LYMPHOCITIC LEUKEMIA : WHY AND WHEN ?
Abstract 885 | PDF Downloads 560 HTML Downloads 470 | DOI https://doi.org/10.4084/mjhid.2010.018Page e2010018
Original Articles
POOR HEMOPOIETIC STEM CELL MOBILIZERS IN MULTIPLE MYELOMA : A SINGLE INSTITUTION EXPERIENCE
Abstract 874 | PDF Downloads 510 HTML Downloads 499 | DOI https://doi.org/10.4084/mjhid.2010.016Page e2010016
CLINICAL ANALYSIS AND OPTIMIZATION OF POST-REMISSION THERAPY FOR ACUTE MYELOID LEUKEMIA PATIENTS WITH MINIMAL RESIDUAL DISEASE AS DETERMINED BY FLOW CYTOMETRY
Abstract 859 | PDF Downloads 568 HTML Downloads 1067 | DOI https://doi.org/10.4084/mjhid.2010.020Page e2010020
Case Reports
PHENYTOIN-ASSOCIATED LYMPHOADENOPATHY MIMICKING A PERIPHERAL T-CELL LYMPHOMA
Abstract 864 | PDF Downloads 585 HTML Downloads 5362 | DOI https://doi.org/10.4084/mjhid.2010.028Page e2010028
Letters to the Editor
Dose-modified lenalidomide induces sustained hematological response in patients with intermediate to high risk myelodysplasia
Abstract 806 | PDF Downloads 459 HTML Downloads 302 | DOI https://doi.org/10.4084/mjhid.2010.012Page e2010012